Abstract
Purpose To test the hypothesis that imaging biomarkers are useful for evaluating in vivo rod photoreceptor cell responses to a mitochondrial protonophore. Methods Intraperitoneal injections of either the mitochondrial uncoupler 2,4 dinitrophenol (DNP) or saline were given to mice with either higher [129S6/eVTac (S6)] or lower [C57BL/6J (B6)] mitochondrial reserve capacities and were studied in dark or light. We measured: (i) the external limiting membrane retinal pigment epithelium region thickness (ELM-RPE; OCT), which decreases substantially with upregulation of a pH-sensitive water removal co-transporter on the apical portion of the RPE, and (ii) the outer retina R1 (= 1/(spin lattice relaxation time (T1), an MRI parameter proportional to oxygen / free radical content. Results In darkness, baseline rod energy production and consumption are relatively high compared to that in light, and additional metabolic stimulation with DNP provoked thinning of the ELMRPE region compared to saline injection in S6 mice; ELM-RPE thickness was unresponsive to DNP in B6 mice. Also, dark-adapted S6 mice given DNP showed a decrease in outer retina R1 values compared to saline injection in the inferior retina. In dark-adapted B6 mice, transretinal R1 values were unresponsive to DNP in superior and inferior regions. In light, with its relatively lower basal rod energy production and consumption, DNP caused ELMRPE thinning in both S6 and B6 mice.Conclusions The present results raise the possibility of non-invasively evaluating the mouse rod mitochondrial energy ecosystem using new DNP-assisted OCT and MRI in vivo assays.
Original language | English |
---|---|
Article number | e0226840 |
Journal | PLoS ONE |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2020 |
Bibliographical note
Publisher Copyright:© 2020 Berkowitz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding
This research was gratefully supported by the National Institutes of Health [RO1 EY026584 (BAB) and R01 AG058171 (BAB)], Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant 14-13A and VA Merit Award 1I01BX003405 (PGS), NIH intramural Research Programs EY000503 and EY000530 to HQ, NEI Core Grant P30 EY04068, and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute, BAB), a Fight for Sight Summer Student Fellowship (CR), and Wayne State University School of Medicine Medical Student Summer Research Fellowships (HKO and JJ).
Funders | Funder number |
---|---|
Kresge Eye Institute | |
National Institutes of Health (NIH) | R01 AG058171, EY000503, EY000530, RO1 EY026584, P30 EY04068 |
U.S. Department of Veterans Affairs | 1I01BX003405 |
Research to Prevent Blindness | |
Fight for Sight Inc | |
Wayne State University School of Medicine | |
Kentucky Spinal Cord and Head Injury Research Trust | 14-13A |
ASJC Scopus subject areas
- General